Analyst Consensus ?
ConsensusHold52 ratings
Bullish2140.4%
Neutral2751.9%
Bearish47.7%
Regions Financial Corporation · RF · FY2024 Q4 · Calendar Q1 2025
Regions Financial: Growth Plan Meets Expense and Credit Risks
Regions Financial enters 2025 with a credible growth framework built on deposits, fee businesses, targeted hiring, and technology. The thesis is supported by management's confident tone and stated franchise advantages, but it depends on converting investment into operating leverage while controlling credit and funding risks.
Reported Before market openNYSEFinancial Services
$23.39B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $0.55
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $1.86B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-1.3%
Event window
SPY move
+1.0%
Same window
Abnormal move
-2.3%
Stock minus SPY
Volume
1.8×
Versus trailing sessions
Subsequent drift
+1.9%
Up to 20 sessions
RFSPY benchmark
Ask FN2 about RF FY2024 Q4
Transcript, numbers and history already loaded
What drove RF's -1.3% move after FY2024 Q4 earnings?What changed in RF's guidance and outlook in FY2024 Q4?Give me the bull and bear case for RF after FY2024 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, management provided a fuller 2025 operating plan: about 1% loan growth, 2–5% net interest income growth, strategic hiring, new lending and deposit systems, and a higher held-to-maturity securities target. The emphasis shifted from reaffirming broad targets toward execution across growth markets, technology, and capital management.
Guidance delta
Management maintained its outlook, including modest 2025 loan growth, 2–5% net interest income growth, and a CET1 target of 9.25–9.75%.
Key takeaways
- Management highlighted record 2024 earnings, an 18% ROE, and strength in Capital Markets, Treasury Management, and Wealth Management.
- The 2025 plan centers on modest loan growth, fee-income expansion, technology upgrades, and hiring about 140 bankers.
- The deposit franchise remains a stated advantage, while higher expenses, charge-offs, and regulatory capital changes are key watchpoints.
Management priorities
- Hire bankers in priority markets.
- Deploy new loan and deposit technology systems.
- Expand fee-based businesses and mortgage-servicing rights.
- Maintain capital ratios while returning capital through dividends and repurchases.
Follow RF with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$27.2Current
$18Low
$28.1Average
$36High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 19, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Oct 14, 2026 |
| UBS | Neutral | Neutral | Maintain | Oct 5, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 2, 2026 |
| Evercore ISI Group | Underperform | Underperform | Maintain | Oct 1, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Sep 28, 2026 |
| Truist Securities | Hold | Hold | Maintain | Sep 23, 2026 |
| Baird | Neutral | Underperform | Upgrade | Sep 18, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 20, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | Jul 20, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 20, 2026 |
| Wells Fargo | Underweight | Underweight | Maintain | Jul 6, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Apr 20, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Mar 30, 2026 |
| Barclays | Underweight | Underweight | Maintain | Jan 5, 2026 |
| Stephens & Co. | Equal Weight | Overweight | Downgrade | Oct 14, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 22, 2025 |
| Compass Point | Buy | Buy | Maintain | Dec 10, 2024 |
| Deutsche Bank | Buy | Hold | Upgrade | Oct 24, 2024 |
| Argus Research | Buy | Hold | Upgrade | Oct 24, 2024 |
| Wedbush | Outperform | Outperform | Maintain | Oct 21, 2024 |
| B of A Securities | Neutral | Neutral | Maintain | Jul 22, 2024 |
| Jefferies | Buy | Buy | Maintain | Jul 3, 2024 |
| Odeon Capital | Hold | Buy | Downgrade | Nov 13, 2023 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Dec 1, 2022 |
| Raymond James | Market Perform | Outperform | Downgrade | Nov 21, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 25, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jul 20, 2020 |
| Nomura | Neutral | Neutral | Maintain | Apr 7, 2020 |
| Janney Montgomery Scott | Buy | Neutral | Upgrade | Jan 21, 2020 |
| Janney Capital | Buy | Neutral | Upgrade | Jan 21, 2020 |
| BMO Capital | Market Perform | Outperform | Downgrade | Nov 12, 2019 |
| Citi | Sell | Neutral | Downgrade | Oct 8, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Jul 11, 2019 |
| Sandler O'Neill | Buy | Hold | Upgrade | Mar 25, 2019 |
| B. Riley FBR | Neutral | Neutral | Maintain | May 5, 2018 |
| B. Riley Securities | Neutral | Neutral | Maintain | Apr 24, 2018 |
| FBR Capital | Neutral | Buy | Downgrade | Oct 10, 2017 |
| Susquehanna | Neutral | Positive | Downgrade | Dec 1, 2016 |
| PiperJaffray | Neutral | Overweight | Downgrade | Nov 16, 2016 |
| Bernstein | Market Perform | Outperform | Downgrade | Aug 16, 2016 |
| Keefe Bruyette & Woods | Market Perform | Underperform | Upgrade | Jun 6, 2016 |
| Macquarie | Neutral | Outperform | Downgrade | Apr 1, 2016 |
| Sterne Agee CRT | Buy | Buy | Maintain | Oct 8, 2015 |
| Sterne Agee | Buy | Buy | Maintain | Oct 8, 2015 |
| Guggenheim | Buy | Neutral | Upgrade | Aug 28, 2015 |
| Wunderlich Securities | Hold | Buy | Downgrade | Jan 21, 2015 |
| Wunderlich | Hold | Buy | Downgrade | Jan 21, 2015 |
| Miller Tabak | Buy | Hold | Upgrade | Aug 8, 2014 |
| ISI Group | Buy | Buy | Maintain | Oct 7, 2013 |
| Sandler O'Neil | Buy | Hold | Upgrade | Mar 6, 2013 |
| Rafferty Capital | Buy | Buy | Maintain | Feb 28, 2013 |
| Drexel Hamilton | Hold | Hold | Maintain | Oct 2, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $27.2. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Cantor Fitzgerald | Analyst unavailable | $32 | $27.01 | +17.6% | Oct 14, 2026 |
| Truist Financial | Analyst unavailable | $31 | $27.6 | +14.0% | Sep 23, 2026 |
| Morgan Stanley | Analyst unavailable | $36 | $30.42 | +32.4% | Sep 8, 2026 |
| Deutsche Bank | Analyst unavailable | $34 | $30.7 | +25.0% | Aug 27, 2026 |
| Cantor Fitzgerald | Dave Rochester | $35 | $31.11 | +28.7% | Jul 21, 2026 |
| Truist Financial | Analyst unavailable | $34 | $31.11 | +25.0% | Jul 21, 2026 |
| D.A. Davidson | Analyst unavailable | $34 | $31.3 | +25.0% | Jul 20, 2026 |
| RBC Capital | Analyst unavailable | $34 | $31.65 | +25.0% | Jul 20, 2026 |
| Jefferies | David Chiaverini | $32 | $31.65 | +17.6% | Jul 17, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $34 | $30.92 | +25.0% | Jul 15, 2026 |
| Evercore ISI | Analyst unavailable | $31 | $30.36 | +14.0% | Jul 6, 2026 |
| D.A. Davidson | Analyst unavailable | $33 | $30.28 | +21.3% | Jul 6, 2026 |
| Robert W. Baird | Analyst unavailable | $28 | $30.28 | +2.9% | Jul 6, 2026 |
| Morgan Stanley | Analyst unavailable | $35 | $30.16 | +28.7% | Jun 29, 2026 |
| Truist Financial | Analyst unavailable | $30 | $28.41 | +10.3% | Apr 21, 2026 |
| RBC Capital | Analyst unavailable | $31 | $28.38 | +14.0% | Apr 20, 2026 |
| D.A. Davidson | Analyst unavailable | $32 | $28.13 | +17.6% | Apr 20, 2026 |
| UBS | Analyst unavailable | $30 | $30.48 | +10.3% | Feb 4, 2026 |
| Piper Sandler | Analyst unavailable | $31 | $27.77 | +14.0% | Jan 20, 2026 |
| Morgan Stanley | Analyst unavailable | $31 | $27.77 | +14.0% | Jan 19, 2026 |
| Wells Fargo | Analyst unavailable | $30 | $28.52 | +10.3% | Jan 16, 2026 |
| Goldman Sachs | Analyst unavailable | $32 | $28.18 | +17.6% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $30 | $27.56 | +10.3% | Jan 5, 2026 |
| Truist Financial | Analyst unavailable | $29 | $27.78 | +6.6% | Dec 22, 2025 |
| Stephens | Analyst unavailable | $27 | $24.56 | -0.7% | Oct 14, 2025 |
| Evercore ISI | John Pancari | $29 | $26.5 | +6.6% | Sep 30, 2025 |
| Morgan Stanley | Analyst unavailable | $32 | $26.63 | +17.6% | Sep 29, 2025 |
| Cantor Fitzgerald | Dave Rochester | $30 | $26.82 | +10.3% | Sep 9, 2025 |
| Barclays | Jason Goldberg | $27 | $26.24 | -0.7% | Jul 21, 2025 |
| Stephens | Terry McEvoy | $26 | $24.08 | -4.4% | Oct 29, 2024 |
| Argus Research | Kevin Heal | $26 | $23.78 | -4.4% | Oct 24, 2024 |
| Deutsche Bank | Matt O'Connor | $26 | $23.64 | -4.4% | Oct 24, 2024 |
| Truist Financial | Brandon King | $26 | $23.82 | -4.4% | Oct 21, 2024 |
| D.A. Davidson | Peter Winter | $29 | $23.82 | +6.6% | Oct 21, 2024 |
| Evercore ISI | John Pancari | $26 | $22.54 | -4.4% | Oct 2, 2024 |
| Wedbush | David Chiaverini | $28 | $22.91 | +2.9% | Sep 24, 2024 |
| Citigroup | Keith Horowitz | $26 | $22.72 | -4.4% | Sep 19, 2024 |
| Piper Sandler | Scott Siefers | $23 | $23.07 | -15.4% | Sep 3, 2024 |
| Morgan Stanley | Betsy Graseck | $28 | $22.43 | +2.9% | Jul 30, 2024 |
| D.A. Davidson | Peter Winter | $26 | $22.39 | -4.4% | Jul 22, 2024 |
| Truist Financial | Brandon King | $23 | $22.39 | -15.4% | Jul 22, 2024 |
| Robert W. Baird | David George | $21 | $22.09 | -22.8% | Jul 22, 2024 |
| RBC Capital | Gerard Cassidy | $23 | $22.09 | -15.4% | Jul 22, 2024 |
| Wells Fargo | Mike Mayo | $22 | $22.09 | -19.1% | Jul 21, 2024 |
| Jefferies | Ken Usdin | $24 | $20.09 | -11.8% | Jul 3, 2024 |
| UBS | Erika Najarian | $22 | $20.51 | -19.1% | Apr 4, 2024 |
| Piper Sandler | Scott Siefers | $15 | $14.1 | -44.9% | Oct 25, 2023 |
| Barclays | Analyst unavailable | $29 | $21.92 | +6.6% | Jan 3, 2023 |
| D.A. Davidson | Analyst unavailable | $25 | $20.71 | -8.1% | Dec 21, 2022 |
| Morgan Stanley | Analyst unavailable | $28 | $20.4 | +2.9% | Dec 16, 2022 |
| Jefferies | Ken Usdin | $22 | $18.92 | -19.1% | Jul 11, 2022 |
| UBS | Erika Najarian | $32 | $24.59 | +17.6% | Jan 12, 2022 |
| Evercore ISI | John Pancari | $27 | $23.88 | -0.7% | Nov 16, 2021 |
| Odeon Capital Group LLC | Richard Bove | $27.7 | $23.8 | +1.8% | Nov 10, 2021 |
| Piper Sandler | Stephen Scouten | $28 | $23.85 | +2.9% | Oct 25, 2021 |
| Wells Fargo | Mike Mayo | $24 | $21.49 | -11.8% | Oct 4, 2021 |
| KBW | David Konrad | $18 | $19.12 | -33.8% | Jul 6, 2021 |
| Compass Point | Dave Rochester | $25 | $22.19 | -8.1% | May 18, 2021 |
Track every rating change on RF the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationRegions Financial Corporation (RF) operates as a financial holding company, delivering a comprehensive array of banking and related services to both individual consumers and corporate entities. The firm's operations are strategically divided into three principal divisions: Corporate Bank, Consumer Bank, and Wealth Management. The Corporate Bank segment specializes in commercial banking solutions. Its extensive offerings include various lending options such as commercial and industrial loans, commercial real estate financing, and investor real estate credit. Furthermore, it provides equipment lease financing, manages diverse deposit products, and offers sophisticated capital markets services like securities underwriting and placement, loan syndication, foreign exchange, derivatives, and merger and acquisition advisory, along with other consulting services. This segment primarily serves corporate clients, middle-market businesses, and developers and investors in commercial real estate.…
Historical context
All RF earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FITB Fifth Third Bancorp | FY2026 Q3 · Calendar Q4 2026 | — | +0.8% | Fifth Third completes Comerica integration as deposits and PPNR grow |
| IBN ICICI Bank Limited | FY2027 Q2 · Calendar Q4 2026 | +1.0% | — | ICICI Bank sustains strong growth, but funding weighs on margins |
| HDB HDFC Bank Limited | FY2027 Q2 · Calendar Q4 2026 | -2.0% | — | HDFC Bank: Strong deposits and asset quality, margins under pressure |
| MTB-PH M&T Bank Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.2% | — | M&T Bank: Loan Growth Holds Up as Rates Pressure Margins |
| MTB-PJ M&T Bank Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.2% | — | M&T: Deposit growth supports margins as AI use expands |
| RF-PE Regions Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | +10.3% | — | Regions Financial: Fee Growth and Credit Quality Support Q3 |
Latest beats and misses
Who reports nextBeat on EPS
Missed on EPS
Get the RF recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-01-03T00:04:36.538277+00:00
- Polygon adjusted daily market bars · 2026-10-19T21:50:52.762079+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-19T21:50:52.758401+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-19. For educational purposes only; not investment advice.